ENTX
ENTX
NASDAQ · Biotechnology

Entera Bio Ltd

$1.14
+0.03 (+2.70%)
As of Apr 1, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
211.9K
Net Income
-11,185,824
Gross Margin
5.0%
Profit Margin
-5,271.3%
Rev Growth
-31.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 5.0% 5.0% 38.1% 38.1%
Operating Margin -5,295.6% -4,766.0% -24.8% -21.3%
Profit Margin -5,271.3% -5,007.7% -30.8% -22.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 211.9K 310.6K 9.20M 8.70M
Gross Profit 10.5K 15.4K 3.50M 3.31M
Operating Income -11,220,592 -14,802,891 -2,286,472 -1,856,846
Net Income -11,185,824 -14,757,023 -2,830,498 -1,987,756
Gross Margin 5.0% 5.0% 38.1% 38.1%
Operating Margin -5,295.6% -4,766.0% -24.8% -21.3%
Profit Margin -5,271.3% -5,007.7% -30.8% -22.8%
Rev Growth -31.8% -31.8% +9.2% +11.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 7.94M 8.67M
Total Equity 25.38M 23.96M
D/E Ratio 0.31 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -11,185,824 -15,576,858 -2,581,372 -2,786,589
Free Cash Flow -3,568,526 -2,022,520